Abstract:Background: Nasopharyngeal carcinoma (NPC) is a malignant epithelial carcinoma arising from the nasopharyngeal mucosal lining. Diagnosis of NPC at early stage can improve the outcome of patients and facilitate reduction in cancer mortality. The most significant change between cancer cells and normal cells is the variation of cell nucleus. Therefore, accurately detecting the biochemical changes in nucleus between cancer cells and normal cells has great potential to explore diagnostic molecular markers for NPC. Highly sensitive surface-enhanced Raman scattering (SERS) could reflect the biochemical changes in the process of cell cancerization at the molecular level. However, rapid nuclear targeting SERS detection remains a challenge. Results: A novel and accurate nuclear-targeting SERS detection method based on electroporation was proposed. With the assistance of electric pulses, nuclear-targeting nanoprobes were rapidly introduced into different NPC cells (including CNE1, CNE2, C666 cell lines) and normal nasopharyngeal epithelial cells (NP69 cell line), respectively. Under the action of nuclear localization signaling peptides (NLS), the nanoprobes entering cells were located to the nucleus, providing high-quality nuclear SERS signals. Hematoxylin and eosin (H&E) staining and in situ cell SERS imaging confirmed the excellent nuclear targeting performance of the nanoprobes developed in this study. The comparison of SERS signals indicated that there were subtle differences in the biochemical components between NPC cells and normal nasopharyngeal cells. Furthermore, SERS spectra combined with principal component analysis (PCA) and linear discriminant analysis (LDA) were employed to diagnose and distinguish NPC cell samples, and high sensitivity, specificity, and accuracy were obtained in the screening of NPC cells from normal nasopharyngeal epithelial cells. Significance: To the best of our knowledge, this is the first study that employing nuclear-targeting SERS testing to screen nasopharyngeal carcinoma cells. Based on the electroporation technology, nanoprobes can be rapidly introduced into living cells for intracellular biochemical detection. Nuclear-targeting SERS detection can analyze the biochemical changes in the nucleus of cancer cells at the molecular level, which has great potential for early cancer screening and cytotoxicity analysis of anticancer drugs.

Identification of different tumor states in nasopharyngeal cancer using surface-enhanced Raman spectroscopy combined with Lasso-PLS-DA algorithm

Label-free Blood Plasma Test Based on Surface-Enhanced Raman Scattering for Tumor Stages Detection in Nasopharyngeal Cancer.

Molecular separation-assisted label-free SERS combined with machine learning for nasopharyngeal cancer screening and radiotherapy resistance prediction

Nasopharyngeal Cancer Detection Based on Blood Plasma Surface-Enhanced Raman Spectroscopy and Multivariate Analysis.

Label-free Discrimination of Different Stage Nasopharyngeal Carcinoma Tissue Based on Raman Spectroscopy.

A Novel Nasopharyngeal Cancer Detection Based on Plasma SERS Combined with PCA-LDA Statistical Analysis

Non-Invasive Detection of Nasopharyngeal Carcinoma Using Saliva Surface-Enhanced Raman Spectroscopy

Development Of A Rapid Macro-Raman Spectroscopy System For Nasopharyngeal Cancer Detection Based On Surface-Enhanced Raman Spectroscopy

Surface-enhanced Raman Scattering Spectroscopy for Potential Noninvasive Nasopharyngeal Cancer Detection

Early discrimination of nasopharyngeal carcinoma based on tissue deoxyribose nucleic acid surface-enhanced Raman spectroscopy analysis.

Detection of Nasopharyngeal Carcinoma Based on Human Saliva Surface-Enhanced Raman Spectroscopy

Rapid Detection of Nasopharyngeal Cancer Using Raman Spectroscopy and Multivariate Statistical Analysis.

Study on Gastric Cancer Blood Plasma Based on Surface-Enhanced Raman Spectroscopy Combined with Multivariate Analysis.

Nasopharyngeal carcinoma cell screening based on the electroporation-SERS spectroscopy

The Application Value of Raman Spectra for Serum in Early Nasopharyngeal Carcinoma Diagnosis

Label-free diagnosis of lung cancer with tissue-slice surface-enhanced Raman spectroscopy and statistical analysis

SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma

Real-time in vivo cancer staging of nasopharyngeal carcinoma patients with rapid fiberoptic Raman endoscopy

Nasopharyngeal carcinoma cell screening based on nuclear targeting Surface-Enhanced Raman Scattering (SERS) detection

Label-free surface-enhanced Raman spectroscopy of serum based on multivariate statistical analysis for the diagnosis and staging of lung adenocarcinoma